×
View 2022 Brochure
Secure Your Spot Among Your Peers!Final Weeks to Register >>

Advancing Biopharma R&D, Business Analytics, and Decision Making

In today’s ever-changing landscape of pharmaceutical R&D, drug development program and portfolio management, portfolio prioritization, capacity management, resource forecasting, risk mitigation, and strategic decision-making are paramount.  Cambridge Healthtech Institute’s Biopharma Strategy Series presents Executive Decision Making for Pharma and Biotech offers a comprehensive platform for high-level discussions, interactive sessions, networking opportunities, breakout roundtables, and personalized 1:1 meetings. Attendees will leave with new tools and organizational strategies to optimize project planning, portfolio insights and decision making; and align resource planning, allocation, and capacity management with portfolio prioritization.

Alumni Organizations

Alumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni LogosAlumni Logos

2024 Keynote Speakers

Michelle Shogren

Michelle Shogren

CEO & Owner, Innovate in What You Do!
Senior Director of Innovation, Pharma R&D Clinical Operations, Bayer

Mary Lou Panzano

Mary Lou Panzano

Founder and CEO, Panzano Enterprises LLC
Former Vice President, Internal Communications, Bayer

Mathilde Bryse

Mathilde Bryse

Head of R&D Strategy, Sanofi

Michael Myers, PhD

Michael Myers, PhD

Associate Vice President, LRL, Project Management—Due Diligence, Eli Lilly and Company

Peter Ray

Peter Ray

Vice President, Head of, Portfolio Analytics, Novartis

Leslie Lippard

Leslie Lippard

Senior Director, Portfolio, Analytics, Alnylam

Melquiades de Jesus

Melquiades de Jesus

Senior Director, R&D PMO Business Capabilities, Jazz Pharmaceuticals

2024 Advisory Board

Michael Ferrante

Michael Ferrante

Executive Director, Portfolio Prioritization, Global Regulatory Affairs & Clinical Safety, Merck

Sean Gallagher

Sean Gallagher

Director, Capacity Management and Business Analytics, Janssen

Leslie Lippard

Leslie Lippard

Senior Director, Portfolio Analytics, Alnylam Pharmaceuticals

Michael Myers

Michael Myers

Associate Vice President, LRL Project Management - Due Diligence, Eli Lilly & Co.

Joe Stalder

Joe Stalder

Vice President, Program Management, Zentalis Pharmaceuticals

Key Contacts

For meeting questions and suggestions, please contact:

Bridget Kotelly

Bridget Kotelly
Senior Conference Director
(+1) 781-972-5404
Email

For partnering and sponsorship information, please contact:

Kristin Skahan

Kristin Skahan
Business Development Manager
(+1) 781-972-5431
Email

For media and association partnerships, please contact:

Ellen Farrar

Ellen Farrar
Senior Marketing Manger
(+1) 781-972-1343
Email